Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)

NCT05267821 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT05267821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05267821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
June 14, 2022
Completion date
August 31, 2028
Enrollment
500 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric sepsis-induced multiple organ dysfunction syndrome (mods)